Annual Retained Earnings
$878.66 M
+$145.07 M+19.78%
December 31, 2023
Summary
- As of February 20, 2025, JAZZ annual retained earnings is $878.66 million, with the most recent change of +$145.07 million (+19.78%) on December 31, 2023.
- During the last 3 years, JAZZ annual retained earnings has fallen by -$281.24 million (-24.25%).
- JAZZ annual retained earnings is now -24.25% below its all-time high of $1.16 billion, reached on December 31, 2020.
Performance
JAZZ Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$936.23 M
+$65.05 M+7.47%
September 30, 2024
Summary
- As of February 20, 2025, JAZZ quarterly retained earnings is $936.23 million, with the most recent change of +$65.05 million (+7.47%) on September 30, 2024.
- Over the past year, JAZZ quarterly retained earnings has increased by +$51.93 million (+5.87%).
- JAZZ quarterly retained earnings is now -26.96% below its all-time high of $1.28 billion, reached on March 31, 2021.
Performance
JAZZ Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
JAZZ Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | +5.9% |
| 3 y3 years | -24.3% | +5.9% |
| 5 y5 years | +4.5% | +5.9% |
JAZZ Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.8% | -5.8% | +27.6% |
| 5 y | 5-year | -24.3% | +19.8% | -27.0% | +27.6% |
| alltime | all time | -24.3% | +273.1% | -27.0% | +282.2% |
Jazz Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $936.23 M(+7.5%) |
| Jun 2024 | - | $871.18 M(+0.8%) |
| Mar 2024 | - | $864.04 M(-1.7%) |
| Dec 2023 | $878.66 M(+19.8%) | $878.66 M(-0.6%) |
| Sep 2023 | - | $884.30 M(+8.9%) |
| Jun 2023 | - | $811.85 M(+1.1%) |
| Mar 2023 | - | $803.01 M(+9.5%) |
| Dec 2022 | $733.59 M(-11.6%) | $733.59 M(-24.7%) |
| Sep 2022 | - | $974.31 M(-2.0%) |
| Jun 2022 | - | $993.96 M(+3.6%) |
| Mar 2022 | - | $959.35 M(+15.6%) |
| Dec 2021 | $830.23 M(-28.4%) | $830.23 M(-4.1%) |
| Sep 2021 | - | $865.58 M(-5.8%) |
| Jun 2021 | - | $918.41 M(-28.3%) |
| Mar 2021 | - | $1.28 B(+10.5%) |
| Dec 2020 | $1.16 B(+8.6%) | $1.16 B(+13.0%) |
| Sep 2020 | - | $1.03 B(+16.9%) |
| Jun 2020 | - | $878.25 M(+13.9%) |
| Mar 2020 | - | $770.93 M(-27.8%) |
| Dec 2019 | $1.07 B(+27.0%) | $1.07 B(-3.3%) |
| Sep 2019 | - | $1.10 B(+8.1%) |
| Jun 2019 | - | $1.02 B(+24.6%) |
| Mar 2019 | - | $819.85 M(-2.5%) |
| Dec 2018 | $841.05 M(-8.4%) | $841.05 M(-25.5%) |
| Sep 2018 | - | $1.13 B(+12.8%) |
| Jun 2018 | - | $1.00 B(+7.7%) |
| Mar 2018 | - | $929.05 M(+1.2%) |
| Dec 2017 | $917.96 M(+73.6%) | $917.96 M(+26.1%) |
| Sep 2017 | - | $728.12 M(+5.5%) |
| Jun 2017 | - | $690.16 M(+14.7%) |
| Mar 2017 | - | $601.52 M(+13.7%) |
| Dec 2016 | $528.91 M(+74.7%) | $528.91 M(+67.7%) |
| Sep 2016 | - | $315.42 M(-2.9%) |
| Jun 2016 | - | $324.84 M(+34.0%) |
| Mar 2016 | - | $242.44 M(-19.9%) |
| Dec 2015 | $302.69 M | $302.69 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $260.18 M(+43.1%) |
| Jun 2015 | - | $181.83 M(+91.3%) |
| Mar 2015 | - | $95.07 M(+173.9%) |
| Dec 2014 | $34.70 M(+87.3%) | $34.70 M(-200.1%) |
| Sep 2014 | - | -$34.67 M(-35.7%) |
| Jun 2014 | - | -$53.95 M(-27.2%) |
| Mar 2014 | - | -$74.12 M(-499.9%) |
| Dec 2013 | $18.53 M(-130.2%) | $18.53 M(-793.0%) |
| Sep 2013 | - | -$2.67 M(-90.9%) |
| Jun 2013 | - | -$29.26 M(+63.8%) |
| Mar 2013 | - | -$17.87 M(-70.8%) |
| Dec 2012 | -$61.30 M(-82.5%) | -$61.30 M(-76.6%) |
| Sep 2012 | - | -$261.85 M(-11.3%) |
| Jun 2012 | - | -$295.06 M(-8.4%) |
| Mar 2012 | - | -$322.20 M(-7.9%) |
| Dec 2011 | -$349.88 M(-26.3%) | -$349.88 M(-9.7%) |
| Sep 2011 | - | -$387.36 M(-7.7%) |
| Jun 2011 | - | -$419.84 M(-7.3%) |
| Mar 2011 | - | -$453.04 M(-4.6%) |
| Dec 2010 | -$474.87 M(-6.5%) | -$474.87 M(-7.4%) |
| Jun 2010 | - | -$512.57 M(+1.3%) |
| Mar 2010 | - | -$506.18 M(-0.3%) |
| Dec 2009 | -$507.64 M(+1.4%) | -$507.64 M(-1.1%) |
| Sep 2009 | - | -$513.30 M(+0.3%) |
| Jun 2009 | - | -$511.63 M(-0.4%) |
| Mar 2009 | - | -$513.80 M(+2.6%) |
| Dec 2008 | -$500.81 M(+58.2%) | -$500.81 M(+12.8%) |
| Sep 2008 | - | -$443.87 M(+6.9%) |
| Jun 2008 | - | -$415.06 M(+14.3%) |
| Mar 2008 | - | -$363.18 M(+14.8%) |
| Dec 2007 | -$316.47 M(+78.1%) | -$316.47 M(+23.4%) |
| Sep 2007 | - | -$256.45 M(+8.2%) |
| Jun 2007 | - | -$237.09 M(+20.2%) |
| Mar 2007 | - | -$197.23 M(+11.0%) |
| Dec 2006 | -$177.64 M(+50.2%) | -$177.64 M(+50.2%) |
| Dec 2005 | -$118.25 M | -$118.25 M |
FAQ
- What is Jazz Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual retained earnings year-on-year change?
- What is Jazz Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly retained earnings year-on-year change?
What is Jazz Pharmaceuticals annual retained earnings?
The current annual retained earnings of JAZZ is $878.66 M
What is the all time high annual retained earnings for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual retained earnings is $1.16 B
What is Jazz Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, JAZZ annual retained earnings has changed by +$145.07 M (+19.78%)
What is Jazz Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of JAZZ is $936.23 M
What is the all time high quarterly retained earnings for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly retained earnings is $1.28 B
What is Jazz Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, JAZZ quarterly retained earnings has changed by +$51.93 M (+5.87%)